Cargando…

Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Paclitaxel

BACKGROUND: The luminal A subtype of breast cancer has a good prognosis and is sensitive to endocrine therapy but is less sensitive to chemotherapy. It is necessary to identify biomarkers to predict chemosensitivity and avoid over-treatment. We hypothesized that miRNAs in the serum might be associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qian, Liu, Mei, Ma, Fei, Luo, Yang, Cai, Ruigang, Wang, Liming, Xu, Ningzhi, Xu, Binghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138038/
https://www.ncbi.nlm.nih.gov/pubmed/25137071
http://dx.doi.org/10.1371/journal.pone.0104870